Organization · Venture Capital
H7 BioCapital
H7 BioCapital is a Silicon Valley-based venture capital firm focused on life sciences, investing in therapeutics and medtech companies. It operates an accelerator program and engages in angel syndication to support healthcare innovation.
Overview
What H7 BioCapital does
What H7 BioCapital is
H7 BioCapital is a Silicon Valley-based venture capital firm focused on life sciences, investing in therapeutics and medtech companies. It operates an accelerator program and engages in angel syndication to support healthcare innovation.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder · Program host
- Last reviewed
- May 3, 2026
Official channels
Find H7 BioCapital elsewhere
Open the official website or a supported primary organization account.
Capability profile
H7 BioCapital as a funder
Investment thesis
H7 BioCapital invests from the demand side, targeting life-science companies with strong licensing and M&A potential. They focus on therapeutics in IND-enabling or clinical stages and medtech products that are post-revenue or clinically validated.
Focus narrative
H7 BioCapital primarily invests in life sciences, focusing on therapeutic companies in IND-enabling or clinical development stages and medtech companies that are post-revenue or have clinical validation. The firm operates an angel syndicate and a healthcare accelerator program, providing mentorship and funding to high-potential startups.
Value beyond capital
H7 BioCapital adds value through its extensive network in the pharmaceutical and medtech industries, providing strategic guidance, mentorship, and access to funding opportunities. Their accelerator program offers educational support and resources to help startups navigate the complexities of the healthcare market.
Focus and fit
- Stages
- Seed · Series A · Series B · Friends and Family · Angel · Accelerator · Pre-IPO
- Sectors
- Biotech · Healthcare · Diagnostics · Medical Devices · Drug Discovery
- Regions
- Global · North America · Europe · East Asia
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Arthrosi Therapeutics
Portfolio context
Notable portfolio companies include Arthrosi Therapeutics, a late-stage biotech focused on gout treatment; Auctus Surgical, developing solutions for pediatric scoliosis surgery; Limmi, a healthcare AI platform; and Cellentia, which uses AI for drug screening. Other companies in the 2024 accelerator cohort include Regenova Pharma, Perfood, and Blink by Globe Biomedical.
Capability profile
H7 BioCapital as a program host
Program thesis
H7 BioCapital aims to advance healthcare innovation through investments in therapeutics and medtech, as well as accelerator programs.
Focus narrative
The firm primarily targets therapeutic companies in IND-enabling or clinical development, as well as medtech companies that are post-revenue or have clinical validation. H7 BioCapital also runs an angel syndicate that invests in high-potential life science and medtech companies from seed to pre-IPO.
Value and support
Founders participating in the accelerator program receive mentorship, funding, and educational support tailored to the unique challenges of the biotech and medtech industries.
Format and cadence
- Typical duration
- 12 weeks
Availability
- Application state
- Not published
Focus and fit
- Stages
- Seed · Pre-IPO · Angel
- Regions
- Global
Programs hosted by H7 BioCapital
These Programs have a direct canonical host relationship to this Organization.
Common questions
What to know about H7 BioCapital
Upseed classifies H7 BioCapital under the Venture Capital organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.